IL18 and nasopharyngeal carcinoma: Studies have revealed that IL-1β/IL-18 can induce T and NK cell activation and killing [19] and that IL-1β recruits neutrophils to control tumor growth and prolong survival in EBV-induced nasopharyngeal carcinoma model animals [44].